Diversified Healthcare Trust $DHC Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. cut its stake in shares of Diversified Healthcare Trust (NASDAQ:DHC) by 2.2% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 256,814 shares of the real estate investment trust’s stock after selling 5,860 shares during the period. Sumitomo Mitsui Trust Group Inc. owned approximately 0.11% of Diversified Healthcare Trust worth $919,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Chicago Partners Investment Group LLC purchased a new position in Diversified Healthcare Trust in the 1st quarter worth about $34,000. Farther Finance Advisors LLC boosted its holdings in shares of Diversified Healthcare Trust by 169.2% in the second quarter. Farther Finance Advisors LLC now owns 10,161 shares of the real estate investment trust’s stock worth $36,000 after buying an additional 6,387 shares during the period. Brooklyn Investment Group increased its position in shares of Diversified Healthcare Trust by 296.3% in the first quarter. Brooklyn Investment Group now owns 18,174 shares of the real estate investment trust’s stock worth $44,000 after acquiring an additional 13,588 shares in the last quarter. Ground Swell Capital LLC acquired a new stake in shares of Diversified Healthcare Trust during the first quarter valued at approximately $45,000. Finally, Smith Asset Management Co. LLC acquired a new stake in shares of Diversified Healthcare Trust during the first quarter valued at approximately $56,000. Institutional investors and hedge funds own 75.98% of the company’s stock.

Diversified Healthcare Trust Stock Performance

DHC stock opened at $4.26 on Friday. The firm has a 50 day moving average of $4.20 and a two-hundred day moving average of $3.57. Diversified Healthcare Trust has a 12 month low of $2.00 and a 12 month high of $4.65. The company has a market capitalization of $1.03 billion, a price-to-earnings ratio of -3.58 and a beta of 2.65. The company has a quick ratio of 6.35, a current ratio of 6.35 and a debt-to-equity ratio of 1.42.

Diversified Healthcare Trust (NASDAQ:DHC) last released its quarterly earnings data on Monday, June 2nd. The real estate investment trust reported $0.01 earnings per share (EPS) for the quarter. The business had revenue of $370.78 million during the quarter. Diversified Healthcare Trust had a negative net margin of 18.83% and a negative return on equity of 14.69%.

Diversified Healthcare Trust Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 13th. Stockholders of record on Monday, October 27th will be paid a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Monday, October 27th. Diversified Healthcare Trust’s dividend payout ratio is -3.36%.

Wall Street Analysts Forecast Growth

DHC has been the subject of a number of recent analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Diversified Healthcare Trust in a research note on Wednesday, October 8th. B. Riley increased their target price on Diversified Healthcare Trust from $4.50 to $5.50 and gave the company a “buy” rating in a report on Wednesday, September 17th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Diversified Healthcare Trust presently has an average rating of “Hold” and a consensus target price of $5.50.

Diversified Healthcare Trust Company Profile

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.